INS and Hyperglycemia: The explanation for the relatively poor percentages may be thatinsufficient doses of insulin were administered to overcome hyperglycemia, because adverseeffects, such as severe hypoglycemia or a significant increase in body mass, were not observed.To increase the efficacy of the therapeutic regimens, higher doses of insulin may be required,although the risks of hypoglycemia and body mass gain would also increase.